M&A Deal Summary

Elanco Acquires Lohman SE

On February 24, 2014, Elanco acquired agriculture company Lohman SE

Acquisition Highlights
  • This is Elanco’s 2nd transaction in the Agriculture sector.
  • This is Elanco’s 2nd transaction in Germany.

M&A Deal Summary

Date 2014-02-24
Target Lohman SE
Sector Agriculture
Buyer(s) Elanco
Deal Type Add-on Acquisition

Target

Lohman SE

Cuxhaven, Germany
Lohmann is a manufacturer of feed additives and poultry vaccines, selling its products in over 80 countries around the world. Headquartered in Cuxhaven, Germany, Lohmann has a production facility there, a vaccine plant in Winslow, Maine, and is represented by 18 subsidiaries in Europe, Asia and North America. The focus of Lohmann is the development of vaccines and food components that help prevent diseases of animals used in food production.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Elanco

Greenfield, Indiana, United States

Category Company
Founded 1954
Sector Life Science
Employees9,000
Revenue 4.4B USD (2024)
DESCRIPTION

Elanco develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco was incorporated in 1954 and is based in Greenfield, Indiana.


DEAL STATS #
Overall 6 of 11
Sector: Agriculture M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 6
Country: Germany M&A 2 of 3
Year: 2014 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-24 Lohmann SE

Cuxhaven, Germany

Lohmann is a manufacturer of feed additives and poultry vaccines, selling its products in over 80 countries around the world. Headquartered in Cuxhaven, Germany, Lohmann has a production facility there, a vaccine plant in Winslow, Maine, and is represented by 18 subsidiaries in Europe, Asia and North America. The focus of Lohmann is the development of vaccines and food components that help prevent diseases of animals used in food production.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-05 Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines

St. Joseph, Montana, United States

Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines is a developer of vaccines for animals. The business also inculded fully integrated manufacturing and R&D site.

Buy $885M